brand logo

Am Fam Physician. 2012;86(1):8

In the STEPS article “Tapentadol (Nucynta) for Treatment of Pain” (May 1, 2012, page 910), the second sentence of the first paragraph incorrectly states that tapentadol blocks the mu opioid receptor (page 910). The sentence should have read: “It has two mechanisms of action: in addition to acting at the mu opioid receptor, tapentadol blocks norepinephrine uptake, although the clinical relevance of this additional action is not known.” The online version of this article has been corrected.

Continue Reading

More in AFP

Copyright © 2012 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.